Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk R Schultz

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
Blood|December 17, 2009
Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF lossHind Medyouf, Xiuhua Gao, Florence Armstrong, et al.
Haematologica|October 6, 2022
CD56bright CD16- natural killer cells as an important regulatory mechanism in chronic graft-<i>versus</i>-host diseaseMadeline Lauener, Shima AzadPour, Sayeh Abdossamadi, et al.
Oncology Letters|January 27, 2017
Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemiaAmina Kariminia, Sabine M Ivison, Vivian M Leung, et al.
Haematologica|March 26, 2026
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupVasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, et al.
Pediatric Blood & Cancer|August 31, 2018
Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patientsMeinolf Suttorp, Markus Metzler, Frederic Millot, et al.
Pediatric Hematology and Oncology|December 29, 2018
Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter studyTal Schechter, Victor A Lewis, Kirk R Schultz, et al.
International Journal of Molecular Sciences|March 14, 2026
Early Marrow Microenvironment Immune Patterns After Hematopoietic Stem Cell Transplant in Pediatric Acute Lymphoblastic Leukemia Are Associated with Later Development of Chronic GvHD and RelapseCatherine M Njeru, Bernard Ng, Sayeh Abdossamadi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in ChildrenDoris M Ponce, Mary Eapen, Rodney Sparapani, et al.
Pediatric Blood & Cancer|April 24, 2020
Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemiaTony H Truong, Jason D Pole, Henrique Bittencourt, et al.
Pediatric Blood & Cancer|July 23, 2019
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working GroupUma Athale, Nobuko Hijiya, Briana C Patterson, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Blood|December 17, 2009
Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF lossHind Medyouf, Xiuhua Gao, Florence Armstrong, et al.
Haematologica|October 6, 2022
CD56bright CD16- natural killer cells as an important regulatory mechanism in chronic graft-<i>versus</i>-host diseaseMadeline Lauener, Shima AzadPour, Sayeh Abdossamadi, et al.
Oncology Letters|January 27, 2017
Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemiaAmina Kariminia, Sabine M Ivison, Vivian M Leung, et al.
Haematologica|March 26, 2026
HLA-DR expression at diagnosis is not predictive of relapse risk post allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia: a report from the Children's Oncology GroupVasant Chinnabhandar, Michael R Verneris, Kirk R Schultz, et al.
Pediatric Blood & Cancer|August 31, 2018
Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patientsMeinolf Suttorp, Markus Metzler, Frederic Millot, et al.
Pediatric Hematology and Oncology|December 29, 2018
Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter studyTal Schechter, Victor A Lewis, Kirk R Schultz, et al.
International Journal of Molecular Sciences|March 14, 2026
Early Marrow Microenvironment Immune Patterns After Hematopoietic Stem Cell Transplant in Pediatric Acute Lymphoblastic Leukemia Are Associated with Later Development of Chronic GvHD and RelapseCatherine M Njeru, Bernard Ng, Sayeh Abdossamadi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in ChildrenDoris M Ponce, Mary Eapen, Rodney Sparapani, et al.
Pediatric Blood & Cancer|April 24, 2020
Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemiaTony H Truong, Jason D Pole, Henrique Bittencourt, et al.
Pediatric Blood & Cancer|July 23, 2019
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working GroupUma Athale, Nobuko Hijiya, Briana C Patterson, et al.
Pageof 22